Regeneron Pharmaceuticals Inc (REGN)
828.82
-14.78
(-1.75%)
USD |
NASDAQ |
Nov 04, 16:00
830.00
+1.18
(+0.14%)
After-Hours: 20:00
Regeneron Pharmaceuticals Net Income (Annual): 3.954B for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 3.954B |
December 31, 2022 | 4.338B |
December 31, 2021 | 8.075B |
December 31, 2020 | 3.513B |
December 31, 2019 | 2.116B |
December 31, 2018 | 2.444B |
December 31, 2017 | 1.198B |
December 31, 2016 | 895.50M |
December 31, 2015 | 636.06M |
December 31, 2014 | 338.13M |
December 31, 2013 | 413.74M |
December 31, 2012 | 750.27M |
December 31, 2011 | -221.76M |
December 31, 2010 | -104.47M |
December 31, 2009 | -67.83M |
December 31, 2008 | -79.13M |
December 31, 2007 | -105.60M |
Date | Value |
---|---|
December 31, 2006 | -102.34M |
December 31, 2005 | -95.45M |
December 31, 2004 | 41.70M |
December 31, 2003 | -107.46M |
December 31, 2002 | -124.38M |
December 31, 2001 | -76.18M |
December 31, 2000 | -23.22M |
December 31, 1999 | -23.10M |
December 31, 1998 | -8.60M |
December 31, 1997 | -11.60M |
December 31, 1996 | -32.40M |
December 31, 1995 | -23.50M |
December 31, 1994 | -30.70M |
December 31, 1993 | -39.90M |
December 31, 1992 | -19.10M |
December 31, 1991 | -4.50M |
December 31, 1990 | -3.30M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
2.116B
Minimum
2019
8.075B
Maximum
2021
4.399B
Average
3.954B
Median
2023
Net Income (Annual) Benchmarks
Amgen Inc | 6.717B |
Eli Lilly and Co | 5.240B |
Pfizer Inc | 2.119B |
Biogen Inc | 1.161B |
Vertex Pharmaceuticals Inc | 3.620B |